Skip to main content
Journal cover image

Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.

Publication ,  Journal Article
Sun, AY
Published in: JACC Clin Electrophysiol
April 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Clin Electrophysiol

DOI

EISSN

2405-5018

Publication Date

April 2019

Volume

5

Issue

4

Start / End Page

513 / 515

Location

United States

Related Subject Headings

  • Procainamide
  • NAV1.5 Voltage-Gated Sodium Channel
  • Humans
  • Brugada Syndrome
  • Anti-Arrhythmia Agents
  • Ajmaline
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sun, A. Y. (2019). Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance. JACC Clin Electrophysiol, 5(4), 513–515. https://doi.org/10.1016/j.jacep.2019.03.003
Sun, Albert Y. “Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.JACC Clin Electrophysiol 5, no. 4 (April 2019): 513–15. https://doi.org/10.1016/j.jacep.2019.03.003.
Sun AY. Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance. JACC Clin Electrophysiol. 2019 Apr;5(4):513–5.
Sun, Albert Y. “Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.JACC Clin Electrophysiol, vol. 5, no. 4, Apr. 2019, pp. 513–15. Pubmed, doi:10.1016/j.jacep.2019.03.003.
Sun AY. Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance. JACC Clin Electrophysiol. 2019 Apr;5(4):513–515.
Journal cover image

Published In

JACC Clin Electrophysiol

DOI

EISSN

2405-5018

Publication Date

April 2019

Volume

5

Issue

4

Start / End Page

513 / 515

Location

United States

Related Subject Headings

  • Procainamide
  • NAV1.5 Voltage-Gated Sodium Channel
  • Humans
  • Brugada Syndrome
  • Anti-Arrhythmia Agents
  • Ajmaline
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology